ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 86 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,157 | +290.7% | 10,458 | +363.2% | 0.00% | – |
| Q2 2023 | $2,088 | +59.6% | 2,258 | +88.2% | 0.00% | – |
| Q1 2023 | $1,308 | -34.6% | 1,200 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 1,200 | -4.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,250 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,250 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 1,250 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 1,250 | +19.0% | 0.00% | – |
| Q3 2021 | $5,000 | – | 1,050 | +2000.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 50 | -99.6% | 0.00% | – |
| Q3 2020 | $101,000 | +3266.7% | 12,676 | +1167.6% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |